DSS treatment resulted in significant reductions in RBC count, HCT, and HGB levels, indicating the development of anemia, along with a decrease in serum iron, UIBC, and TF levels (Figure 3A–C,F,H,I). The gene discussed is CYGB; the disease is anemia.